The APAC market is becoming a key destination for drug development and clinical research. Increase in the number of clinical trial activities in the region is mainly due to reasons such as cost benefits, a large treatment-naïve population, maintenance of...

The oncology accounted for the largest share of the global bioanalytical testing services market in 2021 and is also expected to grow at the highest CAGR. Surging number of clinical trials conducted for cancer is driving the segment growth.